Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion type Assertion NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_head.
- NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion description "[Fibroblast growth factor 21 (FGF21) is emerging as a key regulator of energy homeostasis and presents a novel target for the development of therapies for the treatment of diabetes, cardiovascular disease and obesity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_provenance.
- NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion evidence source_evidence_literature NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_provenance.
- NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion SIO_000772 22587513 NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_provenance.
- NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion wasDerivedFrom befree-20150227 NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_provenance.
- NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_assertion wasGeneratedBy ECO_0000203 NP882959.RAWvPIDAWGsaB9lZLN_4UsY_IDcZ5uGEFxpfFV855vqU0130_provenance.